346 related articles for article (PubMed ID: 18227622)
1. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
[TBL] [Abstract][Full Text] [Related]
3. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
[TBL] [Abstract][Full Text] [Related]
4. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
Van Biervliet S; Devos M; Delhaye T; Van Biervliet JP; Robberecht E; Christophe A
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):109-15. PubMed ID: 18276127
[TBL] [Abstract][Full Text] [Related]
5. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
[TBL] [Abstract][Full Text] [Related]
6. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
7. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
8. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
9. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
Preumont V; Hermans MP; Lebecque P; Buysschaert M
Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E
Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
[TBL] [Abstract][Full Text] [Related]
13. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
14. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.
Keen C; Olin AC; Edentoft A; Gronowitz E; Strandvik B
Chest; 2007 Jun; 131(6):1857-64. PubMed ID: 17400678
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease.
Van Biervliet S; Van Biervliet JP; Robberecht E; Christophe A
Clin Chem Lab Med; 2010 Dec; 48(12):1751-5. PubMed ID: 20961201
[TBL] [Abstract][Full Text] [Related]
16. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
[TBL] [Abstract][Full Text] [Related]
18. Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease.
Risé P; Volpi S; Colombo C; Padoan RF; D'Orazio C; Ghezzi S; Melotti P; Bennato V; Agostoni C; Assael BM; Galli C
J Cyst Fibros; 2010 May; 9(3):228-33. PubMed ID: 20338832
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
20. Predictors of deterioration of lung function in cystic fibrosis.
Schaedel C; de Monestrol I; Hjelte L; Johannesson M; Kornfält R; Lindblad A; Strandvik B; Wahlgren L; Holmberg L
Pediatr Pulmonol; 2002 Jun; 33(6):483-91. PubMed ID: 12001283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
